TECH Shariah Compliance

Screening Methodology: AAOIFI

lock image
LOCKED

Analyst's Ratings

Based on 22 analysts giving stock ratings to Bio-Techne Corp in the past 3 months

Strong
Sell
SellHoldBuyStrong
Buy
Strong Buy
23
Buy
45
Hold
32
Sell
0
Strong Sell
0
Bio-Techne Corp

Bio-Techne Corp. Stock Analysis TECH

United States Health Care Mid Cap
Bio-Techne Corp. is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. The company is headquartered in Minneapolis, Minnesota and currently employs 3,100 full-time employees. The firm's products assist scientific investigations into biological processes and the nature and progress of specific diseases. The Company, in partnership with Wilson Wolf, is creating products such as media and cytokines that are specifically tailored to G-Rex Bioreactors. Its segments include Protein Sciences and Diagnostics and Genomics. The Protein Sciences segment is a developer and manufacturer of biological reagents used in all aspects of life science research, diagnostics and cell and gene therapy. This segment also includes proteomic analytical tools, both manual and automated. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for the regulated diagnostics market, exosome-based molecular diagnostic assays, and tissue biopsy analysis.
Read More

TECH Chart

United States Health Care Mid Cap

Bio-Techne Corp vs S&P 500 Comparative Returns

Analysis of TECH stock performance compared to the broader market (S&P 500) across multiple timeframes.

YTD Performance
  • Bio-Techne Corp... (TEC...) -30.89%
  • S&P 500 -4.27%
Bio-Techne Corp Underperformed S&P 500 by 26.62%
1Y Performance
  • Bio-Techne Corp... (TEC...) -35.39%
  • S&P 500 8.86%
Bio-Techne Corp Underperformed S&P 500 by 44.25%
3Y Performance
  • Bio-Techne Corp... (TEC...) -42.63%
  • S&P 500 37.21%
Bio-Techne Corp Underperformed S&P 500 by 79.84%
5Y Performance
  • Bio-Techne Corp... (TEC...) -26.39%
  • S&P 500 92.3%
Bio-Techne Corp Underperformed S&P 500 by 118.69%

Key Statistics

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$49.78$50.77

Today's Open

$50.00

Volume

4.41M

P/E Ratio (TTM)

44.09

52 Week Range

$46.44$85.57

Market Cap

9.65B

Avg. Volume

2.30M

Dividend Yield

0.68%

Financial Metrics & Statements

  • Per Share Data
  • Ratios
  • Statements
Currency: USD20202021202220232024
Revenue per Share (TTM)
4.8 5.98 7.06 7.21 7.33
EBIT per Share (TTM)
0.98 1.57 1.9 1.86 1.57
Earnings per Share (EPS) (TTM)
6 3.62 6.93 1.81 1.07
Dividend per Share (TTM)
0.32 0.32 0.32 0.32 0.32
EPS Forward
- - 1.66 1.76 1.05

Super Investors

Super Investors are top-performing investors known for their exceptional market strategies and long-term success in wealth creation.

lock-image

Community-Curated Collections ( With TECH )

View All

Community-Curated Collections are thoughtfully selected groups of stocks or assets, curated by investors and experts based on shared themes, values, or investment strategies.

FAQ's

Halal stocks refer to shares of companies that comply with Islamic finance principles, meaning they do not engage in businesses related to alcohol, gambling, pork, or interest-based financial services.